Study
Magnesium Supplements May Boost Lung Function in COPD Patients
A study found that taking oral magnesium supplements improved lung function and quality of life for seniors with COPD.
Summary
In plain language
Researchers explored the effects of oral magnesium supplements on seniors with Chronic Obstructive Pulmonary Disease (COPD). The study showed that those who took magnesium supplements experienced improvements in lung function and overall quality of life over six months. COPD is a common condition in older adults and often coexists with other health issues, impacting daily life. Magnesium, an essential mineral, plays a role in maintaining muscle strength and reducing inflammation. This research suggests that boosting magnesium levels might help seniors with COPD breathe easier and stay more active, though it's important to consult with a healthcare provider before starting any new supplements.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study investigated the impact of oral magnesium supplements on lung function and quality of life in seniors with COPD. Participants were randomly assigned to receive either magnesium supplements or a placebo for six months.
The study found that those taking magnesium showed better lung function and improved scores on quality of life questionnaires compared to the placebo group.
While the findings are promising, the study did not reach its original participant goal, which may affect the strength of the conclusions.
For seniors with COPD, magnesium supplementation could potentially ease breathing and enhance daily activities.
It's advisable to discuss the possibility of magnesium supplementation with your healthcare provider to ensure it's safe and appropriate for you.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Magnesium Supplements May Boost Lung Function in COPD Patients
Published October 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored October 22, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study scored highly due to its rigorous RCT design, comprehensive bias control measures, and detailed reporting. However, it lacked replication evidence and journal quality could not be assessed. The study's relevance to older adults was strong, and conflicts of interest were transparently managed with no industry influence.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 10.0/10 | |
| Bias control | 10.0/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 10.0/10 | |
| Conflicts & funding | 10.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 10.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
This study is a double-blind RCT investigating the effects of oral magnesium supplementation on lung function, physical performance, and quality of life in COPD patients. It found no significant changes in respiratory parameters but suggested a potential anti-inflammatory role for magnesium.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Treatments Evaluated in This Research
Review the interventions studied here and compare them against the broader treatment library.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.